Molecular Nutrition & Food Research · 2011 · 45 citations · 36 references
MedicineOncologyPharmacologyCarcinogenesisMolecular OncologyTumor ProgressionAngiogenesisAngiogenesis In CancerCancer ProgressionLung CancerOncogenic Signaling PathwaysTumor PromotionCell Cycle InhibitionCyclin A RegulationCyclin OverexpressionG2/m TransitionLung CarcinogenesisNeoplastic ProgressionTransgenic MiceVascular Endothelial Growth Factor
SCOPE: We investigated the inhibition of pulmonary tumor formation through treatment with curcumin in transgenic mice. METHODS AND RESULTS: In this study, a strain of transgenic mice carrying human vascular endothelial growth factor A₁₆₅ (hVEGF-A₁₆₅) gene to induce pulmonary tumor was used as an in vivo cancer therapy model. We found that curcumin significantly reduced hVEGF-A₁₆₅ overexpression to normal, specifically in Clara cells of the lungs of transgenic mice, and suppressed the formation of tumors. In addition, we demonstrated a relationship between curcumin treatment and the expression of VEGF, EGFR, ERK2, and Cyclin A at the transcriptional and translational levels. We also noticed a reduction of Cyclin A and Cyclin B after curcumin treatment that had an effect on the cell cycle. Curcumin-induced inhibition of Cyclin A and Cyclin B likely results in decreased progression through S and G2/M phases. These results demonstrated that the expression of proteins involved in the S to M phase transition in transgenic mice is suppressed by curcumin. CONCLUSION: A Data suggest that a blockade of the cell cycle may be a critical mechanism for the observed effects on vasculogenesis and angiogenesis following treatment with curcumin.
36
Cyclin a is required for the onset of DNA replication in mammalian fibroblasts
F Girard, Ulrich Strausfeld, Anne Fernandez et al. · Cell · 1991 · 881 citations
Bharat B. Aggarwal, Shishir Shishodia, Yasunari Takada et al. · Clinical Cancer Research · 2005 · 580 citations
Medicine, Oncology, Pharmacology +14
John D. Potter · The Lancet · 2005 · 452 citations
Agriculture, Nutrition, Oncology +10